Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Knight Insider Profile
4 Followers
Peter Knight, Director at CASI Pharmaceuticals, holds 139.01K shares in CASI Pharmaceuticals (Ticker: CASI), holds ― shares in Par Pharmaceutical Cos. Inc. (Ticker: PRX). Most recently, Peter Knight ― shares of CASI Pharmaceuticals on ― for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-47.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Peter Knight holds in companies
Most Profitable Insider Trade
Stock:
Par Pharmaceutical Cos. Inc.
(PRX)
(PRX)
Rating:Informative Sell
Date:Mar 21, 2012 - Mar 21, 2013
Return:-37.00%
The most profitable trade made by Peter Knight
Peter Knight's Trading History
CASI Pharmaceuticals
―
Director
―
$336.40K
Par Pharmaceutical Cos. Inc.
Oct 02, 2012
―
Uninformative Sell
175.00K
―
List of latest transactions for each holding click on a transaction to see Peter Knight's performance on stock
You May Also Like
Peter Knight insider profile FAQ
What is the percentage of profitable transactions made by Peter Knight?
The percentage of profitable transactions made by Peter Knight is 0%.
What is the average return per transaction made by Peter Knight?
The average return per transaction made by Peter Knight is -47.20%.
What stocks does Peter Knight hold?
Peter Knight holds: CASI, PRX stocks.
What was Peter Knight’s latest transaction?
Peter Knight latest transaction was an Uninformative Buy of ―.
What was Peter Knight's most profitable transaction?
Peter Knight’s most profitable transaction was an Informative Sell of PRX stock on March 21, 2012. The return on the trade was -37.00%.
What is Peter Knight's role in CASI Pharmaceuticals?
Peter Knight's role in CASI Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.